OptimizeRx

OptimizeRx

OPRX· Services· Fiscal year ends in December

CEO pay in FY2025Stock +152.3% in FY2025

Stephen Silvestro is the CEO of OptimizeRx and was paid $2.7M in FY2025 (Dec), up 179%.

Pay$100 in the stock at the end of FY22 → $73
CEO pay is from each OptimizeRx proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Stephen SilvestroFY2025
  2. 2Theresa GrecoFY2025
  3. 3Edward StelmakhFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

OptimizeRx paid its 3 named executives $5.8M in total in FY2025 (Dec). CEO Stephen Silvestro was paid $2.7M of that.

Name
Stephen SilvestroChief Executive Officer
Theresa GrecoChief Commercial OfficerNot disclosedNot disclosed
Edward StelmakhChief Financial & Strategy Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers16

See all

The FY2025 (Dec) proxy of OptimizeRx names 16 peer companies for pay. Among OptimizeRx and these peers, CEO pay was the lowest of 2 and total shareholder return was the lowest of 2.

2nd highest of 2in OptimizeRx and its pay peers, FY2025 (Dec) by CEO pay:

$2.7M$10.5M

2nd highest of 2in OptimizeRx and its pay peers, FY2025 (Dec) by total shareholder return:

$73$92

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board4

See all
  • Lynn O’Connor VosChair · 10 yr on the boardIndependentAudit, Compensation, Nominating and Governance, Strategic—Paid as an executive
  • James LangDirector · 8 yr on the boardIndependentCompensation (Chair), Nominating and Governance—Paid as an executive
  • Patrick SpanglerDirector · 7 yr on the boardIndependentAudit (Chair), Compensation, Strategic—Paid as an executive
  • Gregory WassonDirector · 5 yr on the boardIndependentCompensation, Strategic—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 30, 2026FY2025
Annual report10-KMar 12, 2026FY2025
Proxy statementDEF 14AApr 30, 2025FY2024
Annual report10-KMar 20, 2025FY2024
Proxy statementDEF 14AApr 29, 2024FY2023
Annual report10-KApr 15, 2024FY2023